Dabuzalgron Hydrochloride

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDabuzalgron Hydrochloride
Drug Alias Name达布扎琼盐酸盐dabuzalgronum盐酸达扎格隆达扎格隆盐酸盐盐酸达布扎琼 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha-1a adrenergic receptor agonists
TargetsAlpha-1a adrenergic receptor
Therapy Area/IndicationsUrinary Incontinence
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsUrinary Incontinence

Other Information

ATC CodeN/A
Related LinksKEGG